Cardiac Rhythm Management
banner AtriCure HRS2018 Achieving Optimal Outcomes

 

tmb AtriCure HRS2018 Hybrid Ablation

Location:
Westin Boston Waterfront - Commonwealth Ballroom
425 Summer St, Boston, MA 02210

Date:
Wednesday, May 9, 2018

Time:
11:45AM-12:15PM – Registration, Followed by Plated Lunch
12:15PM-1:45PM – Educational Program

Cardiac Rhythm Management

Agenda

Agenda
   
11:45AM-12:15PM   Registration Followed by Plated Lunch
12:15PM-12:20PM   Welcome and Introductions
David DeLurgio, MD, FACC, FHRS
12:20PM-12:40PM   Insights into the Structural and Mechanistic Basis of Persistent Atrial Fibrillation: Arguments Supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation
Kevin Makati, MD, FACC, FHRS
12:40PM-1:00PM   CONVERGE Trial Rationale and Design
David DeLurgio, MD, FACC, FHRS
1:00PM-1:20PM   DEEP Trial Rationale and Design
Kenneth Ellenbogen, MD
1:20PM-1:45PM   Panel Discussion with Attendee Q&A Session
Panel: David DeLurgio, MD, FACC, FHRS, Kenneth Ellenbogen, MD, Kevin Makati, MD, FACC, FHRS

Cardiac Rhythm Management

Faculty
David DeLurgio, MD, FACC, FHRS
Professor of Medicine                  
Division of Cardiology, Department of Medicine
Emory University School of Medicine
Atlanta, GA

Kenneth Ellenbogen, MD
Martha M. and Harold W. Kimmerling Professor of Cardiology
Chair, Cardiology
VCU School of Medicine
Richmond, VA

Kevin Makati, MD, FACC, FHRS
Rhythm Section Chairperson, Baycare Health Systems
Co-Director Arrhythmia Department, St. Joseph’s Hospital
Tampa, FL

Cardiac Rhythm Management

Commercial Support
This activity is supported through an educational grant from AtriCure

Joint Providership
MediaSphere Medical, LLC and Cine-Med

 

CME Activity Description

Activity Description
This educational activity has been developed to review existing practice gaps with traditional Atrial Fibrillation treatment strategies, and examine the structural mechanistic basis of Persistent Atrial Fibrillation, and clinical evidence supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation. The leading experts will also evaluate the rationale and design of the CONVERGE and DEEP Trials.

The symposium concludes with an expert panel discussion with ample time allotted for attendee Q&A.

Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, cardiologists, surgeons, and other physicians and associated professionals who are dedicated to managing patients with atrial fibrillation.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Review structural and mechanistic basis of Persistent Atrial Fibrillation , and clinical evidence supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation.
  • Evaluate the rationale and design of the CONVEREGE Trial for the treatment of Symptomatic Persistent Atrial Fibrillation.
  • Examine the rationale and design of the DEEP Trial for the treatment of subjects with Persistent or Longstanding Persistent Atrial Fibrillation.

Accreditation Statement

Jointly Accredited Provider TMIn support of improving patient care, this activity has been planned and implemented by Cine-Med and MediaSphere Medical. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Ciné-Med designates this live activity for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1.5 Contact Hours for nurses.

Cardiac Rhythm Management

Disclosure Policy
MediaSphere Medical and Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Cine-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

Non-Endorsement Statement
MediaSphere Medical and Cine-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Cine-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

 

Registration

Registration copy
  1. First Name: *  
    Invalid Input
  2. Middle Name:
    Invalid Input
  3. Last Name: *  
    Invalid Input
  4. Primary Email Address: *  
    Invalid Input
  5. Registration Type: *  
    Invalid Input
  6. Medical Specialty:
    Invalid Input
  7. Institution: *  
    Invalid Input
  8. Mailing Address:*  
    Invalid Input
  9. City: *  
    Invalid Input
  10. State: *  
    Invalid Input
  11. Zip Code:
    Invalid Input
  12. Country:
    Invalid Input
  13. Office Phone:
    Invalid Input
  14. Office Fax:
    Invalid Input
  15. (*) Required Fields
  16. Invalid Input

 

“This program is not part of the Heart Rhythm 2018 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Program Committee. The event is neither sponsored nor endorsed by the Heart Rhythm Society”